ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy

The purpose of this study is to compare any good and bad effects of giving radiation treatment for breast cancer in 3 treatments over about 2 days.

Trial Details

NCT ID
NCT06185205
Phase
PHASE2
Sponsor
Virginia Commonwealth University
Status
RECRUITING
Cancer Type
Lobular Carcinoma Breast Cancer
Interventions
  • Accelerated partial breast irradiation
Locations (sample)
  • Richmond, Virginia, United States|37.55376,-77.46026

Key Eligibility Criteria

  • New diagnosis of ductal carcinoma in situ (DCIS) and/or invasive breast carcinoma per histologic evaluation
  • Age 45-79 at diagnosis
  • Previous lumpectomy with surgical margins histologically free of invasive tumor and DCIS as determined by the pathologist.
  • T stage of Tis, T1, or T2.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lobular Carcinoma Breast Cancer Trials on Trialify →